TGRX-326 Pharmacokinetic Mass Balance
NCT06438367
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
[14C]TGRX-326
Sponsor
Shenzhen TargetRx Co., Ltd.
Collaborators
[object Object]